Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 11, 2022
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
Tue, May 10, 2022
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
Jacob Johnson Maintained (BLFS) at Buy with Decreased Target to $40 on, May 10th, 2022
Jacob Johnson of Stephens & Co., Maintained "BioLife Solutions, Inc." (BLFS) at Buy with Decreased Target from $47 to $40 on, May 10th, 2022.
Jacob has made no other calls on BLFS in the last 4 months.
There is 1 other peer that has a rating on BLFS. Out of the 1 peers that are also analyzing BLFS, 0 agree with Jacob's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jacob
- Suraj Kalia of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $28 on, Monday, April 25th, 2022
